A team approach to the complexities of advanced PC care. As recently as five years ago, there were very few options available for patients with advanced, metastatic prostate cancer,” says Dr. Evan R. Goldfischer, co-CEO of Premier. Today, however, the situation is much brighter. “A number of new drugs have been approved—with new mechanisms of […]
